228 related articles for article (PubMed ID: 34152815)
1. Nitric Oxide-Dependent Electron Transport Chain Inhibition by the Cytochrome
Zeng S; Zhang J; Sun M; Zhang X; Cook GM; Zhang T
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0095621. PubMed ID: 34152815
[TBL] [Abstract][Full Text] [Related]
2. Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.
Foo CS; Lupien A; Kienle M; Vocat A; Benjak A; Sommer R; Lamprecht DA; Steyn AJC; Pethe K; Piton J; Altmann KH; Cole ST
mBio; 2018 Oct; 9(5):. PubMed ID: 30301850
[TBL] [Abstract][Full Text] [Related]
3. Exploiting the synthetic lethality between terminal respiratory oxidases to kill
Kalia NP; Hasenoehrl EJ; Ab Rahman NB; Koh VH; Ang MLT; Sajorda DR; Hards K; Grüber G; Alonso S; Cook GM; Berney M; Pethe K
Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7426-7431. PubMed ID: 28652330
[TBL] [Abstract][Full Text] [Related]
4. Pyrazolo[1,5- a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis.
Lu X; Williams Z; Hards K; Tang J; Cheung CY; Aung HL; Wang B; Liu Z; Hu X; Lenaerts A; Woolhiser L; Hastings C; Zhang X; Wang Z; Rhee K; Ding K; Zhang T; Cook GM
ACS Infect Dis; 2019 Feb; 5(2):239-249. PubMed ID: 30485737
[TBL] [Abstract][Full Text] [Related]
5. Terminal Respiratory Oxidases: A Targetables Vulnerability of Mycobacterial Bioenergetics?
Bajeli S; Baid N; Kaur M; Pawar GP; Chaudhari VD; Kumar A
Front Cell Infect Microbiol; 2020; 10():589318. PubMed ID: 33330134
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Two Novel Inhibitors of the Mycobacterium tuberculosis Cytochrome
Gries R; Dal Molin M; Chhen J; van Gumpel E; Dreyer V; Niemann S; Rybniker J
Antimicrob Agents Chemother; 2023 Jul; 67(7):e0025123. PubMed ID: 37358461
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome bc1-aa3 Oxidase Supercomplex As Emerging and Potential Drug Target Against Tuberculosis.
Sindhu T; Debnath P
Curr Mol Pharmacol; 2022; 15(2):380-392. PubMed ID: 34602044
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach.
Liu Y; Tan Y; Islam MM; Cao Y; Lu X; Zeng S; Hameed HMA; Zhou P; Cai X; Wang S; Mugweru JN; Zhang G; Yin H; Liu J; Nuermberger E; Zhang T
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31843996
[No Abstract] [Full Text] [Related]
9. Targeting the cytochrome bc
Wani MA; Dhaked DK
Mol Divers; 2022 Oct; 26(5):2949-2965. PubMed ID: 34762234
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of (Quinazoline 4-yloxy)acetamide and (4-oxoquinazoline-3(4H)-yl)acetamide derivatives as inhibitors of Mycobacterium tuberculosis bd oxidase.
Kumar A; Kumari N; Bhattacherjee S; Venugopal U; Parwez S; Siddiqi MI; Krishnan MY; Panda G
Eur J Med Chem; 2022 Nov; 242():114639. PubMed ID: 35973312
[TBL] [Abstract][Full Text] [Related]
11. The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd.
Lu P; Asseri AH; Kremer M; Maaskant J; Ummels R; Lill H; Bald D
Sci Rep; 2018 Feb; 8(1):2625. PubMed ID: 29422632
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal and sterilizing activity of sudapyridine-clofazimine-TB47 combined with linezolid or pyrazinamide in a murine model of tuberculosis.
Yu W; Ju Y; Han X; Tian X; Ding J; Wang S; Hameed HMA; Gao Y; Li L; Li Y; Zhong N; Zhang T
Antimicrob Agents Chemother; 2024 May; ():e0012424. PubMed ID: 38690893
[TBL] [Abstract][Full Text] [Related]
13. Carbon metabolism modulates the efficacy of drugs targeting the cytochrome bc
Kalia NP; Shi Lee B; Ab Rahman NB; Moraski GC; Miller MJ; Pethe K
Sci Rep; 2019 Jun; 9(1):8608. PubMed ID: 31197236
[TBL] [Abstract][Full Text] [Related]
14. Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome
Jeffreys LN; Ardrey A; Hafiz TA; Dyer LA; Warman AJ; Mosallam N; Nixon GL; Fisher NE; Hong WD; Leung SC; Aljayyoussi G; Bibby J; Almeida DV; Converse PJ; Fotouhi N; Berry NG; Nuermberger EL; Upton AM; O'Neill PM; Ward SA; Biagini GA
ACS Infect Dis; 2023 Feb; 9(2):221-238. PubMed ID: 36606559
[No Abstract] [Full Text] [Related]
15. Sterilizing Effects of Novel Regimens Containing TB47, Clofazimine, and Linezolid in a Murine Model of Tuberculosis.
Yu W; Yusuf B; Wang S; Tian X; Hameed HMA; Lu Z; Chiwala G; Alam MS; Cook GM; Maslov DA; Zhong N; Zhang T
Antimicrob Agents Chemother; 2021 Sep; 65(10):e0070621. PubMed ID: 34280022
[TBL] [Abstract][Full Text] [Related]
16. Isoniazid Bactericidal Activity Involves Electron Transport Chain Perturbation.
Zeng S; Soetaert K; Ravon F; Vandeput M; Bald D; Kauffmann JM; Mathys V; Wattiez R; Fontaine V
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642937
[TBL] [Abstract][Full Text] [Related]
17. Identification of 4-Amino-Thieno[2,3-
Harrison GA; Mayer Bridwell AE; Singh M; Jayaraman K; Weiss LA; Kinsella RL; Aneke JS; Flentie K; Schene ME; Gaggioli M; Solomon SD; Wildman SA; Meyers MJ; Stallings CL
mSphere; 2019 Sep; 4(5):. PubMed ID: 31511370
[TBL] [Abstract][Full Text] [Related]
18. The cytochrome bd-type quinol oxidase is important for survival of Mycobacterium smegmatis under peroxide and antibiotic-induced stress.
Lu P; Heineke MH; Koul A; Andries K; Cook GM; Lill H; van Spanning R; Bald D
Sci Rep; 2015 May; 5():10333. PubMed ID: 26015371
[TBL] [Abstract][Full Text] [Related]
19. Host immunity increases Mycobacterium tuberculosis reliance on cytochrome bd oxidase.
Cai Y; Jaecklein E; Mackenzie JS; Papavinasasundaram K; Olive AJ; Chen X; Steyn AJC; Sassetti CM
PLoS Pathog; 2021 Jul; 17(7):e1008911. PubMed ID: 34320028
[TBL] [Abstract][Full Text] [Related]
20. Identification of nitric oxide reductase activity in Rhodobacter capsulatus: the electron transport pathway can either use or bypass both cytochrome c2 and the cytochrome bc1 complex.
Bell LC; Richardson DJ; Ferguson SJ
J Gen Microbiol; 1992 Mar; 138(3):437-43. PubMed ID: 1317404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
